Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 312

1.

Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.

Mauri D, Pavlidis N, Ioannidis JP.

J Natl Cancer Inst. 2005 Feb 2;97(3):188-94.

PMID:
15687361
2.

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.

Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Knowling MA, Coppin CM, Weir L, Gelmon K, Le N, Durand R, Coldman AJ, Manji M.

J Natl Cancer Inst. 2005 Jan 19;97(2):116-26.

PMID:
15657341
4.
6.

Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective.

Gebski V, Lagleva M, Keech A, Simes J, Langlands AO.

J Natl Cancer Inst. 2006 Jan 4;98(1):26-38. Erratum in: J Natl Cancer Inst. 2006 Jun 21;98(12):876.

PMID:
16391369
7.

Does adjuvant bisphosphonate in early breast cancer modify the natural course of the disease? A meta-analysis of randomized controlled trials.

Mauri D, Valachis A, Polyzos NP, Tsali L, Mavroudis D, Georgoulias V, Casazza G.

J Natl Compr Canc Netw. 2010 Mar;8(3):279-86.

PMID:
20202461
8.

Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trials.

Cuppone F, Bria E, Carlini P, Milella M, Felici A, Sperduti I, Nisticò C, Terzoli E, Cognetti F, Giannarelli D.

Cancer. 2008 Jul 15;113(2):238-46. doi: 10.1002/cncr.23544.

9.

Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.

Venturini M, Del Mastro L, Aitini E, Baldini E, Caroti C, Contu A, Testore F, Brema F, Pronzato P, Cavazzini G, Sertoli MR, Canavese G, Rosso R, Bruzzi P.

J Natl Cancer Inst. 2005 Dec 7;97(23):1724-33.

PMID:
16333028
10.

The efficacy of zoledronic acid in breast cancer adjuvant therapy: a meta-analysis of randomised controlled trials.

Yan T, Yin W, Zhou Q, Zhou L, Jiang Y, Du Y, Shao Z, Lu J.

Eur J Cancer. 2012 Jan;48(2):187-95. doi: 10.1016/j.ejca.2011.10.021. Epub 2011 Nov 17. Review.

PMID:
22100904
11.

Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study.

Sarid D, Ron IG, Sperber F, Stadler Y, Kahan P, Kovner F, Ben-Yosef R, Marmor S, Grinberg Y, Maimon N, Weinstein J, Yaal-Hahoshen N.

Clin Drug Investig. 2006;26(12):691-701.

PMID:
17274676
12.

Neoadjuvant chemotherapy in stage III breast cancer.

Alassas M, Chu Q, Burton G, Ampil F, Mizell J, Li BD.

Am Surg. 2005 Jun;71(6):487-92.

PMID:
16044927
13.
14.

HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.

Gennari A, Sormani MP, Pronzato P, Puntoni M, Colozza M, Pfeffer U, Bruzzi P.

J Natl Cancer Inst. 2008 Jan 2;100(1):14-20. Epub 2007 Dec 25.

PMID:
18159072
15.

Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.

Evron E, Barzily L, Rakowsky E, Ben-Baruch N, Sulkes J, Rizel S, Fenig E.

Isr Med Assoc J. 2005 Jul;7(7):439-42.

16.

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Tu D, Shepherd LE, Pritchard KI, Livingston RB, Davidson NE, Norton L, Perez EA, Abrams JS, Cameron DA, Palmer MJ, Pater JL.

J Natl Cancer Inst. 2005 Sep 7;97(17):1262-71.

PMID:
16145047
17.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
19.

Breast cancer: role of neoadjuvant therapy.

Ahmed MI, Lennard TW.

Int J Surg. 2009 Oct;7(5):416-20. doi: 10.1016/j.ijsu.2009.06.001. Epub 2009 Jun 12. Review.

20.

Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy.

Oh JL, Dryden MJ, Woodward WA, Yu TK, Tereffe W, Strom EA, Perkins GH, Middleton L, Hunt KK, Giordano SH, Oswald MJ, Domain D, Buchholz TA.

J Clin Oncol. 2006 Nov 1;24(31):4971-5.

PMID:
17075114

Supplemental Content

Support Center